Columbia Care Celebrates Historic Launch of Adult Use Sales at its Two New Jersey Cannabist Dispensaries

Columbia Care Partof First Group of 7 Operators to Receive Approval to Begin Adult Use Sales

NEW YORK--(BUSINESS WIRE)--Apr. 21, 2022-- (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in theU.S., announced that it will begin adult use sales today at its twoNew Jerseydispensaries, both now under the Cannabist brand, inDeptfordandVineland. Cannabist Deptford is located at1692 Clements Bridge RoadinDeptford; Cannabist Vineland is located at1062 N. Delsea Dr.

“This is a momentous time for the voters of the Garden State who have been looking forward to adult use sales, giving new meaning to the phrase ‘good things come to those who wait’,” saidNicholas Vita, CEO ofColumbia Care. “We are grateful to theNew Jersey Cannabis Regulatory Commissionfor giving us the green light to begin sales of our high quality cannabis products to recreational customers onDay OneforNew Jersey, and we are thankful to the local officials and communities for their continued support.New Jerseyis the first of the next wave of east coast states to launch adult use, and we are excited to grow and evolve alongside new social equity entrepreneurs who will help make this local industry a success.”

BothDeptfordandVinelandlocations will open for adult use sales with limited hours, which will expand as demand and market dynamics evolve. Each location will offer medical-only hours, along with medical-only parking spots, pick-up lines and dedicated phone lines to ensure that patient access is unaffected with the onset of adult use sales.

The adult use menu will launch with some of the Company’s most popular flower strains, available in both 3.5g and 7.5 g packages, as well as two vape options. New products and form factors, including concentrated oils, resin, tinctures, lozenges, and soft chews will be added to the adult use menu, as well, after completing the state’s third party testing requirement.

Beyond its two existing dispensaries inDeptfordandVineland,Columbia Careis licensed to operate a third retail location, which is in development. The Company currently operates a 50,000-square-foot cultivation and production facility inVineland, with a secondVinelandfacility currently in development that will provide 270,000 square feet of additional canopy, manufacturing and distribution space, pending regulatory approval.

Columbia Carewill be donating a portion of the proceeds from the Company’s first adult sales to theShiloh Baptist ChurchinVinelandto support their re-entry program.

For hours, menu and dispensary information, visit For medical patient information, visit

AboutColumbia Care

Columbia Careis one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and theEU.Columbia Careoperates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.Columbia Careis one of the original multi-state providers of medical cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information onColumbia Care, please visit

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives inNew Jersey. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10-K datedMarch 31, 2022, filed withU.S. Securities and Exchange Commissionand with the applicable Canadian securities regulatory authorities on SEDAR at and as otherwise described from time to time in documents filed by the Company with Canadian andU.S.securities regulatory authorities.

Lee Ann Evans
Investor Relations

Lindsay Wilson

Source:Columbia Care Inc.

<< Back to Press Releases